3-(Piperazinylpropyl)indoles:  Selective, Orally Bioavailable h5-HT1DReceptor Agonists as Potential Antimigraine Agents

Mark S. Chambers; Leslie J. Street; Simon Goodacre; Sarah C. Hobbs; Peter Hunt; Richard A. Jelley; Victor G. Matassa; Austin J. Reeve; Francine Sternfeld; Margaret S. Beer; Josephine A. Stanton; Denise Rathbone; Alan P. Watt; Angus M. MacLeod

doi:10.1021/jm980569z

journal article Feb 01, 1999

3-(Piperazinylpropyl)indoles: Selective, Orally Bioavailable h5-HT1DReceptor Agonists as Potential Antimigraine Agents

Leslie J. Street Simon Goodacre Sarah C. Hobbs Peter Hunt Richard A. Jelley Victor G. Matassa Austin J. Reeve Francine Sternfeld Margaret S. Beer Josephine A. Stanton Denise Rathbone Alan P. Watt Angus M. MacLeod

Journal of Medicinal Chemistry Vol. 42 No. 4 pp. 691-705 · American Chemical Society (ACS)

View at Publisher Save 10.1021/jm980569z

Topics

No keywords indexed for this article. Browse by subject →

References

36

[1]

Ferrari M. D Neurology (1993)

[2]

Plosker G. L. Drugs (1994)

[3]

Hoyer D. Trends Pharmacol. Sci. (1995) 10.1016/s0165-6147(00)88988-9

[4]

Walsh D. M. Eur. J. Pharmacol. (1995) 10.1016/0014-2999(95)00612-1

[5]

The D Neuropharmacology (1997)

[6]

Hamel E. Serotonin (1996)

[7]

Leysen J. E. Mol. Pharmacol. (1996)

[8]

Pauwels P. J. Eur. J. Pharmacol. (1996)

[9]

Migraine (1996)

[10]

Adham N. Proc. Natl. Acad. Sci. U.S.A. (1993) 10.1073/pnas.90.2.408

[11]

Overshiner C. C. (1996)

[12]

Ottervanger J. P. Eur. J. Clin. Pharmacol. (1994) 10.1007/bf00191159

[13]

Ferro A. Br. J. Clin. Pharmacol. (1995) 10.1111/j.1365-2125.1995.tb05780.x

[14]

Bax W. A. Eur. J. Pharmacol. (1993) 10.1016/0014-2999(93)90995-t

[15]

Kaumann A. J. Circulation (1994) 10.1161/01.cir.90.3.1141

[16]

Ottervanger J. P. CNS Drugs (1995) 10.2165/00023210-199503020-00002

[17]

Ferrari M. D. Trends Pharmacol. Sci. (1993) 10.1016/0165-6147(93)90084-w

[18]

Moskowitz M. A Neurology (1993)

[19]

Yevich J. P. Curr. Med. Chem. (1997) 10.2174/0929867304666220313122326

[20]

Bouchelet I. Mol. Pharmacol. (1996)

[21]

Street L. J. J. Med. Chem. (1995) 10.1021/jm00010a025

[22]

Castro J. L. J. Med. Chem. (1997)

[23]

MacLeod A. M. J. Med. Chem. (1997) 10.1021/jm9704560

[24]

Ihara M. J. Chem. Soc., Perkin Trans. 1 (1989)

[25]

Ihara M. J. Chem. Soc., Perkin Trans. 1 (1993)

[26]

Brodfuehrer P. R. J. Org. Chem. (1997) 10.1021/jo971368q

[27]

Grotjahn D. B. J. Chem. Soc. Chem. Commun. (1981)

[28]

Sternfeld F. Bioorg. Med. Chem. Lett. (1996) 10.1016/0960-894x(96)00324-1

[29]

Bernotas R. C. Tetrahedron Lett. (1996)

[30]

Kane J. M. Tetrahedron Lett. (1980)

[31]

Veldman S. A. Mol. Pharmacol. (1992)

[32]

Lazereno S. Br. J. Pharmacol. (1993)

[33]

Cephalgia (1995)

[34]

Elliot M. Pestic. Sci. (1987)

[35]

Beylin V. G. Org. Prep. Proced. Int. (1987) 10.1080/00304948709354878

[36]

Vedejs E. J. Org. Chem. (1988) 10.1021/jo00245a020

Metrics

23

Citations

36

References

Details

Published: Feb 01, 1999
Vol/Issue: 42(4)
Pages: 691-705

Authors

M

Mark S. Chambers